(1) If an independent cannabis testing laboratory determines that the results of a lab test indicate that a cannabis or cannabis product batch may be unsafe for human use: (a) the independent cannabis testing laboratory shall: (i) report the results and the cannabis or cannabis product batch to: (A) the department; and (B) the cannabis production establishment that prepared the cannabis or cannabis product batch; and (ii) retain possession of the cannabis or cannabis product batch for two weeks in order to investigate the cause of the defective batch and to make a determination; and (b) the cannabis production establishment that prepared the cannabis or cannabis product batch may appeal the determination described in Subsection (1)(a)(ii) to the department.

(a) the independent cannabis testing laboratory shall: (i) report the results and the cannabis or cannabis product batch to: (A) the department; and (B) the cannabis production establishment that prepared the cannabis or cannabis product batch; and (ii) retain possession of the cannabis or cannabis product batch for two weeks in order to investigate the cause of the defective batch and to make a determination; and

(i) report the results and the cannabis or cannabis product batch to: (A) the department; and (B) the cannabis production establishment that prepared the cannabis or cannabis product batch; and

(A) the department; and

(B) the cannabis production establishment that prepared the cannabis or cannabis product batch; and

(ii) retain possession of the cannabis or cannabis product batch for two weeks in order to investigate the cause of the defective batch and to make a determination; and

(b) the cannabis production establishment that prepared the cannabis or cannabis product batch may appeal the determination described in Subsection (1)(a)(ii) to the department.

(2) If the department determines, under Subsection (1)(a)(ii) or following an appeal under Subsection (1)(b), that a cannabis or cannabis product prepared by a cannabis production establishment is unsafe for human consumption, the department may seize, embargo, or destroy, in the same manner as a cannabis production establishment under Section 4-41a-405, the cannabis or cannabis product batch.

(3) If an independent cannabis testing laboratory determines that the results of a lab test indicate that the cannabinoid content of a cannabis or cannabis product batch diverges more than 10% from the amounts the label indicates, the cannabis processing facility may not sell the cannabis or cannabis product batch unless the facility replaces the incorrect label with a label that correctly indicates the cannabinoid content.